Global iPSC-Derived Neural Progenitor Cells Market Growth 2026-2032
The global iPSC-Derived Neural Progenitor Cells market size is predicted to grow from US$ 70.43 million in 2025 to US$ 202 million in 2032; it is expected to grow at a CAGR of 16.2% from 2026 to 2032.
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer’s disease, Parkinson’s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “iPSC-Derived Neural Progenitor Cells Industry Forecast” looks at past sales and reviews total world iPSC-Derived Neural Progenitor Cells sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC-Derived Neural Progenitor Cells sales for 2026 through 2032. With iPSC-Derived Neural Progenitor Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC-Derived Neural Progenitor Cells industry.
This Insight Report provides a comprehensive analysis of the global iPSC-Derived Neural Progenitor Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on iPSC-Derived Neural Progenitor Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC-Derived Neural Progenitor Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC-Derived Neural Progenitor Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC-Derived Neural Progenitor Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC-Derived Neural Progenitor Cells market by product type, application, key manufacturers and key regions and countries.
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer’s disease, Parkinson’s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “iPSC-Derived Neural Progenitor Cells Industry Forecast” looks at past sales and reviews total world iPSC-Derived Neural Progenitor Cells sales in 2025, providing a comprehensive analysis by region and market sector of projected iPSC-Derived Neural Progenitor Cells sales for 2026 through 2032. With iPSC-Derived Neural Progenitor Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world iPSC-Derived Neural Progenitor Cells industry.
This Insight Report provides a comprehensive analysis of the global iPSC-Derived Neural Progenitor Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on iPSC-Derived Neural Progenitor Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global iPSC-Derived Neural Progenitor Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for iPSC-Derived Neural Progenitor Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global iPSC-Derived Neural Progenitor Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of iPSC-Derived Neural Progenitor Cells market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Cryopreserved Cells
- Cell and Media Kits
- Differentiation Kits
- Disease-Specific Cells
- Custom or GMP-Compatible Cells
- Other Formats
Segmentation by Donor or Disease Background:
- Healthy Control Donor
- Patient-Derived Disease Model
- Gene-Edited Reporter Line
- Immune-Matched or HLA Line
- Custom Donor Background
- Other Donor Background
Segmentation by Differentiation Stage:
- Neural Stem Cells
- Neural Progenitor Cells
- Regional Neural Progenitors
- Lineage-Committed Progenitors
- Mature Neural Derivatives
- Other Differentiation Stages
Segmentation by Quality Grade:
- Research Use Only Grade
- Assay-Ready Grade
- Xeno-Free Defined Grade
- GMP-Compatible Grade
- Custom Validated Grade
- Other Quality Grades
Segmentation by Application:
- Neurological Disease Modeling
- Neurotoxicity and Safety Testing
- Drug Screening and Target Validation
- Neural Differentiation and Organoid Culture
- Regenerative Medicine Research
- Other Applications
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- STEMCELL Technologies
- Merck
- Applied StemCell
- Axol Bioscience
- Tempo Bioscience
- Creative Bioarray
- ACROBiosystems
- ATCC
- Cell Applications
- AcceGen
Key Questions Addressed in this Report
- What is the 10-year outlook for the global iPSC-Derived Neural Progenitor Cells market?
- What factors are driving iPSC-Derived Neural Progenitor Cells market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do iPSC-Derived Neural Progenitor Cells market opportunities vary by end market size?
- How does iPSC-Derived Neural Progenitor Cells break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for iPSC-Derived Neural Progenitor Cells by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for iPSC-Derived Neural Progenitor Cells by Country/Region, 2021, 2025 & 2032
2.2 iPSC-Derived Neural Progenitor Cells Segment by Type
2.2.1 Cryopreserved Cells
2.2.2 Cell and Media Kits
2.2.3 Differentiation Kits
2.2.4 Disease-Specific Cells
2.2.5 Custom or GMP-Compatible Cells
2.2.6 Other Formats
2.2.7 iPSC-Derived Neural Progenitor Cells Sales by Type
2.2.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
2.2.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Type (2021-2026)
2.3 iPSC-Derived Neural Progenitor Cells Segment by Donor or Disease Background
2.3.1 Healthy Control Donor
2.3.2 Patient-Derived Disease Model
2.3.3 Gene-Edited Reporter Line
2.3.4 Immune-Matched or HLA Line
2.3.5 Custom Donor Background
2.3.6 Other Donor Background
2.3.7 iPSC-Derived Neural Progenitor Cells Sales by Donor or Disease Background
2.3.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Donor or Disease Background (2021-2026)
2.3.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Donor or Disease Background (2021-2026)
2.3.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Donor or Disease Background (2021-2026)
2.4 iPSC-Derived Neural Progenitor Cells Segment by Differentiation Stage
2.4.1 Neural Stem Cells
2.4.2 Neural Progenitor Cells
2.4.3 Regional Neural Progenitors
2.4.4 Lineage-Committed Progenitors
2.4.5 Mature Neural Derivatives
2.4.6 Other Differentiation Stages
2.4.7 iPSC-Derived Neural Progenitor Cells Sales by Differentiation Stage
2.4.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Differentiation Stage (2021-2026)
2.4.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Differentiation Stage (2021-2026)
2.4.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Differentiation Stage (2021-2026)
2.5 iPSC-Derived Neural Progenitor Cells Segment by Quality Grade
2.5.1 Research Use Only Grade
2.5.2 Assay-Ready Grade
2.5.3 Xeno-Free Defined Grade
2.5.4 GMP-Compatible Grade
2.5.5 Custom Validated Grade
2.5.6 Other Quality Grades
2.5.7 iPSC-Derived Neural Progenitor Cells Sales by Quality Grade
2.5.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Quality Grade (2021-2026)
2.5.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Quality Grade (2021-2026)
2.5.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Quality Grade (2021-2026)
2.6 iPSC-Derived Neural Progenitor Cells Segment by Application
2.6.1 Neurological Disease Modeling
2.6.2 Neurotoxicity and Safety Testing
2.6.3 Drug Screening and Target Validation
2.6.4 Neural Differentiation and Organoid Culture
2.6.5 Regenerative Medicine Research
2.6.6 Other Applications
2.6.7 iPSC-Derived Neural Progenitor Cells Sales by Application
2.6.7.1 Global iPSC-Derived Neural Progenitor Cells Sale Market Share by Application (2021-2026)
2.6.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Application (2021-2026)
2.6.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global iPSC-Derived Neural Progenitor Cells Breakdown Data by Company
3.1.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales by Company (2021-2026)
3.1.2 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Company (2021-2026)
3.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue by Company (2021-2026)
3.2.1 Global iPSC-Derived Neural Progenitor Cells Revenue by Company (2021-2026)
3.2.2 Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Company (2021-2026)
3.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Company
3.4 Key Manufacturers iPSC-Derived Neural Progenitor Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers iPSC-Derived Neural Progenitor Cells Product Location Distribution
3.4.2 Players iPSC-Derived Neural Progenitor Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IPSC-DERIVED NEURAL PROGENITOR CELLS BY GEOGRAPHIC REGION
4.1 World Historic iPSC-Derived Neural Progenitor Cells Market Size by Geographic Region (2021-2026)
4.1.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales by Geographic Region (2021-2026)
4.1.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic iPSC-Derived Neural Progenitor Cells Market Size by Country/Region (2021-2026)
4.2.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales by Country/Region (2021-2026)
4.2.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC-Derived Neural Progenitor Cells Sales Growth
4.4 APAC iPSC-Derived Neural Progenitor Cells Sales Growth
4.5 Europe iPSC-Derived Neural Progenitor Cells Sales Growth
4.6 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Growth
5 AMERICAS
5.1 Americas iPSC-Derived Neural Progenitor Cells Sales by Country
5.1.1 Americas iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026)
5.1.2 Americas iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026)
5.2 Americas iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
5.3 Americas iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC-Derived Neural Progenitor Cells Sales by Region
6.1.1 APAC iPSC-Derived Neural Progenitor Cells Sales by Region (2021-2026)
6.1.2 APAC iPSC-Derived Neural Progenitor Cells Revenue by Region (2021-2026)
6.2 APAC iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
6.3 APAC iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe iPSC-Derived Neural Progenitor Cells by Country
7.1.1 Europe iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026)
7.1.2 Europe iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026)
7.2 Europe iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
7.3 Europe iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells by Country
8.1.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026)
8.1.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026)
8.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
8.3 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of iPSC-Derived Neural Progenitor Cells
10.3 Manufacturing Process Analysis of iPSC-Derived Neural Progenitor Cells
10.4 Industry Chain Structure of iPSC-Derived Neural Progenitor Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 iPSC-Derived Neural Progenitor Cells Distributors
11.3 iPSC-Derived Neural Progenitor Cells Customer
12 WORLD FORECAST REVIEW FOR IPSC-DERIVED NEURAL PROGENITOR CELLS BY GEOGRAPHIC REGION
12.1 Global iPSC-Derived Neural Progenitor Cells Market Size Forecast by Region
12.1.1 Global iPSC-Derived Neural Progenitor Cells Forecast by Region (2027-2032)
12.1.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global iPSC-Derived Neural Progenitor Cells Forecast by Type (2027-2032)
12.7 Global iPSC-Derived Neural Progenitor Cells Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 STEMCELL Technologies
13.1.1 STEMCELL Technologies Company Information
13.1.2 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 STEMCELL Technologies Main Business Overview
13.1.5 STEMCELL Technologies Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.2.3 Merck iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Applied StemCell
13.3.1 Applied StemCell Company Information
13.3.2 Applied StemCell iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Applied StemCell Main Business Overview
13.3.5 Applied StemCell Latest Developments
13.4 Axol Bioscience
13.4.1 Axol Bioscience Company Information
13.4.2 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Axol Bioscience Main Business Overview
13.4.5 Axol Bioscience Latest Developments
13.5 Tempo Bioscience
13.5.1 Tempo Bioscience Company Information
13.5.2 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tempo Bioscience Main Business Overview
13.5.5 Tempo Bioscience Latest Developments
13.6 Creative Bioarray
13.6.1 Creative Bioarray Company Information
13.6.2 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Creative Bioarray Main Business Overview
13.6.5 Creative Bioarray Latest Developments
13.7 ACROBiosystems
13.7.1 ACROBiosystems Company Information
13.7.2 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ACROBiosystems Main Business Overview
13.7.5 ACROBiosystems Latest Developments
13.8 ATCC
13.8.1 ATCC Company Information
13.8.2 ATCC iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.8.3 ATCC iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 ATCC Main Business Overview
13.8.5 ATCC Latest Developments
13.9 Cell Applications
13.9.1 Cell Applications Company Information
13.9.2 Cell Applications iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cell Applications Main Business Overview
13.9.5 Cell Applications Latest Developments
13.10 AcceGen
13.10.1 AcceGen Company Information
13.10.2 AcceGen iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AcceGen Main Business Overview
13.10.5 AcceGen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for iPSC-Derived Neural Progenitor Cells by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for iPSC-Derived Neural Progenitor Cells by Country/Region, 2021, 2025 & 2032
2.2 iPSC-Derived Neural Progenitor Cells Segment by Type
2.2.1 Cryopreserved Cells
2.2.2 Cell and Media Kits
2.2.3 Differentiation Kits
2.2.4 Disease-Specific Cells
2.2.5 Custom or GMP-Compatible Cells
2.2.6 Other Formats
2.2.7 iPSC-Derived Neural Progenitor Cells Sales by Type
2.2.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
2.2.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Type (2021-2026)
2.3 iPSC-Derived Neural Progenitor Cells Segment by Donor or Disease Background
2.3.1 Healthy Control Donor
2.3.2 Patient-Derived Disease Model
2.3.3 Gene-Edited Reporter Line
2.3.4 Immune-Matched or HLA Line
2.3.5 Custom Donor Background
2.3.6 Other Donor Background
2.3.7 iPSC-Derived Neural Progenitor Cells Sales by Donor or Disease Background
2.3.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Donor or Disease Background (2021-2026)
2.3.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Donor or Disease Background (2021-2026)
2.3.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Donor or Disease Background (2021-2026)
2.4 iPSC-Derived Neural Progenitor Cells Segment by Differentiation Stage
2.4.1 Neural Stem Cells
2.4.2 Neural Progenitor Cells
2.4.3 Regional Neural Progenitors
2.4.4 Lineage-Committed Progenitors
2.4.5 Mature Neural Derivatives
2.4.6 Other Differentiation Stages
2.4.7 iPSC-Derived Neural Progenitor Cells Sales by Differentiation Stage
2.4.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Differentiation Stage (2021-2026)
2.4.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Differentiation Stage (2021-2026)
2.4.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Differentiation Stage (2021-2026)
2.5 iPSC-Derived Neural Progenitor Cells Segment by Quality Grade
2.5.1 Research Use Only Grade
2.5.2 Assay-Ready Grade
2.5.3 Xeno-Free Defined Grade
2.5.4 GMP-Compatible Grade
2.5.5 Custom Validated Grade
2.5.6 Other Quality Grades
2.5.7 iPSC-Derived Neural Progenitor Cells Sales by Quality Grade
2.5.7.1 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Quality Grade (2021-2026)
2.5.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Quality Grade (2021-2026)
2.5.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Quality Grade (2021-2026)
2.6 iPSC-Derived Neural Progenitor Cells Segment by Application
2.6.1 Neurological Disease Modeling
2.6.2 Neurotoxicity and Safety Testing
2.6.3 Drug Screening and Target Validation
2.6.4 Neural Differentiation and Organoid Culture
2.6.5 Regenerative Medicine Research
2.6.6 Other Applications
2.6.7 iPSC-Derived Neural Progenitor Cells Sales by Application
2.6.7.1 Global iPSC-Derived Neural Progenitor Cells Sale Market Share by Application (2021-2026)
2.6.7.2 Global iPSC-Derived Neural Progenitor Cells Revenue and Market Share by Application (2021-2026)
2.6.7.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global iPSC-Derived Neural Progenitor Cells Breakdown Data by Company
3.1.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales by Company (2021-2026)
3.1.2 Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Company (2021-2026)
3.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue by Company (2021-2026)
3.2.1 Global iPSC-Derived Neural Progenitor Cells Revenue by Company (2021-2026)
3.2.2 Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Company (2021-2026)
3.3 Global iPSC-Derived Neural Progenitor Cells Sale Price by Company
3.4 Key Manufacturers iPSC-Derived Neural Progenitor Cells Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers iPSC-Derived Neural Progenitor Cells Product Location Distribution
3.4.2 Players iPSC-Derived Neural Progenitor Cells Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IPSC-DERIVED NEURAL PROGENITOR CELLS BY GEOGRAPHIC REGION
4.1 World Historic iPSC-Derived Neural Progenitor Cells Market Size by Geographic Region (2021-2026)
4.1.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales by Geographic Region (2021-2026)
4.1.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic iPSC-Derived Neural Progenitor Cells Market Size by Country/Region (2021-2026)
4.2.1 Global iPSC-Derived Neural Progenitor Cells Annual Sales by Country/Region (2021-2026)
4.2.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue by Country/Region (2021-2026)
4.3 Americas iPSC-Derived Neural Progenitor Cells Sales Growth
4.4 APAC iPSC-Derived Neural Progenitor Cells Sales Growth
4.5 Europe iPSC-Derived Neural Progenitor Cells Sales Growth
4.6 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Growth
5 AMERICAS
5.1 Americas iPSC-Derived Neural Progenitor Cells Sales by Country
5.1.1 Americas iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026)
5.1.2 Americas iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026)
5.2 Americas iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
5.3 Americas iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC iPSC-Derived Neural Progenitor Cells Sales by Region
6.1.1 APAC iPSC-Derived Neural Progenitor Cells Sales by Region (2021-2026)
6.1.2 APAC iPSC-Derived Neural Progenitor Cells Revenue by Region (2021-2026)
6.2 APAC iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
6.3 APAC iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe iPSC-Derived Neural Progenitor Cells by Country
7.1.1 Europe iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026)
7.1.2 Europe iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026)
7.2 Europe iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
7.3 Europe iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells by Country
8.1.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026)
8.1.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026)
8.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026)
8.3 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of iPSC-Derived Neural Progenitor Cells
10.3 Manufacturing Process Analysis of iPSC-Derived Neural Progenitor Cells
10.4 Industry Chain Structure of iPSC-Derived Neural Progenitor Cells
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 iPSC-Derived Neural Progenitor Cells Distributors
11.3 iPSC-Derived Neural Progenitor Cells Customer
12 WORLD FORECAST REVIEW FOR IPSC-DERIVED NEURAL PROGENITOR CELLS BY GEOGRAPHIC REGION
12.1 Global iPSC-Derived Neural Progenitor Cells Market Size Forecast by Region
12.1.1 Global iPSC-Derived Neural Progenitor Cells Forecast by Region (2027-2032)
12.1.2 Global iPSC-Derived Neural Progenitor Cells Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global iPSC-Derived Neural Progenitor Cells Forecast by Type (2027-2032)
12.7 Global iPSC-Derived Neural Progenitor Cells Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 STEMCELL Technologies
13.1.1 STEMCELL Technologies Company Information
13.1.2 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 STEMCELL Technologies Main Business Overview
13.1.5 STEMCELL Technologies Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.2.3 Merck iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Applied StemCell
13.3.1 Applied StemCell Company Information
13.3.2 Applied StemCell iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Applied StemCell Main Business Overview
13.3.5 Applied StemCell Latest Developments
13.4 Axol Bioscience
13.4.1 Axol Bioscience Company Information
13.4.2 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Axol Bioscience Main Business Overview
13.4.5 Axol Bioscience Latest Developments
13.5 Tempo Bioscience
13.5.1 Tempo Bioscience Company Information
13.5.2 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tempo Bioscience Main Business Overview
13.5.5 Tempo Bioscience Latest Developments
13.6 Creative Bioarray
13.6.1 Creative Bioarray Company Information
13.6.2 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Creative Bioarray Main Business Overview
13.6.5 Creative Bioarray Latest Developments
13.7 ACROBiosystems
13.7.1 ACROBiosystems Company Information
13.7.2 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ACROBiosystems Main Business Overview
13.7.5 ACROBiosystems Latest Developments
13.8 ATCC
13.8.1 ATCC Company Information
13.8.2 ATCC iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.8.3 ATCC iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 ATCC Main Business Overview
13.8.5 ATCC Latest Developments
13.9 Cell Applications
13.9.1 Cell Applications Company Information
13.9.2 Cell Applications iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Cell Applications Main Business Overview
13.9.5 Cell Applications Latest Developments
13.10 AcceGen
13.10.1 AcceGen Company Information
13.10.2 AcceGen iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
13.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 AcceGen Main Business Overview
13.10.5 AcceGen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. iPSC-Derived Neural Progenitor Cells Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. iPSC-Derived Neural Progenitor Cells Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cryopreserved Cells
Table 4. Major Players of Cell and Media Kits
Table 5. Major Players of Differentiation Kits
Table 6. Major Players of Disease-Specific Cells
Table 7. Major Players of Custom or GMP-Compatible Cells
Table 8. Major Players of Other Formats
Table 9. Global iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 10. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Table 11. Global iPSC-Derived Neural Progenitor Cells Revenue by Type (2021-2026) & ($ million)
Table 12. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Type (2021-2026)
Table 13. Global iPSC-Derived Neural Progenitor Cells Sale Price by Type (2021-2026) & (US$/Dose)
Table 14. Major Players of Healthy Control Donor
Table 15. Major Players of Patient-Derived Disease Model
Table 16. Major Players of Gene-Edited Reporter Line
Table 17. Major Players of Immune-Matched or HLA Line
Table 18. Major Players of Custom Donor Background
Table 19. Major Players of Other Donor Background
Table 20. Global iPSC-Derived Neural Progenitor Cells Sales by Donor or Disease Background (2021-2026) & (K Dose)
Table 21. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Donor or Disease Background (2021-2026)
Table 22. Global iPSC-Derived Neural Progenitor Cells Revenue by Donor or Disease Background (2021-2026) & ($ million)
Table 23. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Donor or Disease Background (2021-2026)
Table 24. Global iPSC-Derived Neural Progenitor Cells Sale Price by Donor or Disease Background (2021-2026) & (US$/Dose)
Table 25. Major Players of Neural Stem Cells
Table 26. Major Players of Neural Progenitor Cells
Table 27. Major Players of Regional Neural Progenitors
Table 28. Major Players of Lineage-Committed Progenitors
Table 29. Major Players of Mature Neural Derivatives
Table 30. Major Players of Other Differentiation Stages
Table 31. Global iPSC-Derived Neural Progenitor Cells Sales by Differentiation Stage (2021-2026) & (K Dose)
Table 32. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Differentiation Stage (2021-2026)
Table 33. Global iPSC-Derived Neural Progenitor Cells Revenue by Differentiation Stage (2021-2026) & ($ million)
Table 34. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Differentiation Stage (2021-2026)
Table 35. Global iPSC-Derived Neural Progenitor Cells Sale Price by Differentiation Stage (2021-2026) & (US$/Dose)
Table 36. Major Players of Research Use Only Grade
Table 37. Major Players of Assay-Ready Grade
Table 38. Major Players of Xeno-Free Defined Grade
Table 39. Major Players of GMP-Compatible Grade
Table 40. Major Players of Custom Validated Grade
Table 41. Major Players of Other Quality Grades
Table 42. Global iPSC-Derived Neural Progenitor Cells Sales by Quality Grade (2021-2026) & (K Dose)
Table 43. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Quality Grade (2021-2026)
Table 44. Global iPSC-Derived Neural Progenitor Cells Revenue by Quality Grade (2021-2026) & ($ million)
Table 45. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Quality Grade (2021-2026)
Table 46. Global iPSC-Derived Neural Progenitor Cells Sale Price by Quality Grade (2021-2026) & (US$/Dose)
Table 47. Global iPSC-Derived Neural Progenitor Cells Sale by Application (2021-2026) & (K Dose)
Table 48. Global iPSC-Derived Neural Progenitor Cells Sale Market Share by Application (2021-2026)
Table 49. Global iPSC-Derived Neural Progenitor Cells Revenue by Application (2021-2026) & ($ million)
Table 50. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application (2021-2026)
Table 51. Global iPSC-Derived Neural Progenitor Cells Sale Price by Application (2021-2026) & (US$/Dose)
Table 52. Global iPSC-Derived Neural Progenitor Cells Sales by Company (2021-2026) & (K Dose)
Table 53. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Company (2021-2026)
Table 54. Global iPSC-Derived Neural Progenitor Cells Revenue by Company (2021-2026) & ($ millions)
Table 55. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Company (2021-2026)
Table 56. Global iPSC-Derived Neural Progenitor Cells Sale Price by Company (2021-2026) & (US$/Dose)
Table 57. Key Manufacturers iPSC-Derived Neural Progenitor Cells Producing Area Distribution and Sales Area
Table 58. Players iPSC-Derived Neural Progenitor Cells Products Offered
Table 59. iPSC-Derived Neural Progenitor Cells Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 60. New Products and Potential Entrants
Table 61. Market M&A Activity & Strategy
Table 62. Global iPSC-Derived Neural Progenitor Cells Sales by Geographic Region (2021-2026) & (K Dose)
Table 63. Global iPSC-Derived Neural Progenitor Cells Sales Market Share Geographic Region (2021-2026)
Table 64. Global iPSC-Derived Neural Progenitor Cells Revenue by Geographic Region (2021-2026) & ($ millions)
Table 65. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Geographic Region (2021-2026)
Table 66. Global iPSC-Derived Neural Progenitor Cells Sales by Country/Region (2021-2026) & (K Dose)
Table 67. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Country/Region (2021-2026)
Table 68. Global iPSC-Derived Neural Progenitor Cells Revenue by Country/Region (2021-2026) & ($ millions)
Table 69. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country/Region (2021-2026)
Table 70. Americas iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026) & (K Dose)
Table 71. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Country (2021-2026)
Table 72. Americas iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026) & ($ millions)
Table 73. Americas iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 74. Americas iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 75. APAC iPSC-Derived Neural Progenitor Cells Sales by Region (2021-2026) & (K Dose)
Table 76. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Region (2021-2026)
Table 77. APAC iPSC-Derived Neural Progenitor Cells Revenue by Region (2021-2026) & ($ millions)
Table 78. APAC iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 79. APAC iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 80. Europe iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026) & (K Dose)
Table 81. Europe iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026) & ($ millions)
Table 82. Europe iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 83. Europe iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 84. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026) & (K Dose)
Table 85. Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country (2021-2026)
Table 86. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 87. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 88. Key Market Drivers & Growth Opportunities of iPSC-Derived Neural Progenitor Cells
Table 89. Key Market Challenges & Risks of iPSC-Derived Neural Progenitor Cells
Table 90. Key Industry Trends of iPSC-Derived Neural Progenitor Cells
Table 91. iPSC-Derived Neural Progenitor Cells Raw Material
Table 92. Key Suppliers of Raw Materials
Table 93. iPSC-Derived Neural Progenitor Cells Distributors List
Table 94. iPSC-Derived Neural Progenitor Cells Customer List
Table 95. Global iPSC-Derived Neural Progenitor Cells Sales Forecast by Region (2027-2032) & (K Dose)
Table 96. Global iPSC-Derived Neural Progenitor Cells Revenue Forecast by Region (2027-2032) & ($ millions)
Table 97. Americas iPSC-Derived Neural Progenitor Cells Sales Forecast by Country (2027-2032) & (K Dose)
Table 98. Americas iPSC-Derived Neural Progenitor Cells Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 99. APAC iPSC-Derived Neural Progenitor Cells Sales Forecast by Region (2027-2032) & (K Dose)
Table 100. APAC iPSC-Derived Neural Progenitor Cells Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 101. Europe iPSC-Derived Neural Progenitor Cells Sales Forecast by Country (2027-2032) & (K Dose)
Table 102. Europe iPSC-Derived Neural Progenitor Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 103. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Forecast by Country (2027-2032) & (K Dose)
Table 104. Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 105. Global iPSC-Derived Neural Progenitor Cells Sales Forecast by Type (2027-2032) & (K Dose)
Table 106. Global iPSC-Derived Neural Progenitor Cells Revenue Forecast by Type (2027-2032) & ($ millions)
Table 107. Global iPSC-Derived Neural Progenitor Cells Sales Forecast by Application (2027-2032) & (K Dose)
Table 108. Global iPSC-Derived Neural Progenitor Cells Revenue Forecast by Application (2027-2032) & ($ millions)
Table 109. STEMCELL Technologies Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 110. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 111. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 112. STEMCELL Technologies Main Business
Table 113. STEMCELL Technologies Latest Developments
Table 114. Merck Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 116. Merck iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 117. Merck Main Business
Table 118. Merck Latest Developments
Table 119. Applied StemCell Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 120. Applied StemCell iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 121. Applied StemCell iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 122. Applied StemCell Main Business
Table 123. Applied StemCell Latest Developments
Table 124. Axol Bioscience Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 125. Axol Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 126. Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 127. Axol Bioscience Main Business
Table 128. Axol Bioscience Latest Developments
Table 129. Tempo Bioscience Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 130. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 131. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 132. Tempo Bioscience Main Business
Table 133. Tempo Bioscience Latest Developments
Table 134. Creative Bioarray Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 135. Creative Bioarray iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 136. Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 137. Creative Bioarray Main Business
Table 138. Creative Bioarray Latest Developments
Table 139. ACROBiosystems Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 140. ACROBiosystems iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 141. ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 142. ACROBiosystems Main Business
Table 143. ACROBiosystems Latest Developments
Table 144. ATCC Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 145. ATCC iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 146. ATCC iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 147. ATCC Main Business
Table 148. ATCC Latest Developments
Table 149. Cell Applications Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 150. Cell Applications iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 151. Cell Applications iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 152. Cell Applications Main Business
Table 153. Cell Applications Latest Developments
Table 154. AcceGen Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 155. AcceGen iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 156. AcceGen iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 157. AcceGen Main Business
Table 158. AcceGen Latest Developments
Table 1. iPSC-Derived Neural Progenitor Cells Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. iPSC-Derived Neural Progenitor Cells Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cryopreserved Cells
Table 4. Major Players of Cell and Media Kits
Table 5. Major Players of Differentiation Kits
Table 6. Major Players of Disease-Specific Cells
Table 7. Major Players of Custom or GMP-Compatible Cells
Table 8. Major Players of Other Formats
Table 9. Global iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 10. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Table 11. Global iPSC-Derived Neural Progenitor Cells Revenue by Type (2021-2026) & ($ million)
Table 12. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Type (2021-2026)
Table 13. Global iPSC-Derived Neural Progenitor Cells Sale Price by Type (2021-2026) & (US$/Dose)
Table 14. Major Players of Healthy Control Donor
Table 15. Major Players of Patient-Derived Disease Model
Table 16. Major Players of Gene-Edited Reporter Line
Table 17. Major Players of Immune-Matched or HLA Line
Table 18. Major Players of Custom Donor Background
Table 19. Major Players of Other Donor Background
Table 20. Global iPSC-Derived Neural Progenitor Cells Sales by Donor or Disease Background (2021-2026) & (K Dose)
Table 21. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Donor or Disease Background (2021-2026)
Table 22. Global iPSC-Derived Neural Progenitor Cells Revenue by Donor or Disease Background (2021-2026) & ($ million)
Table 23. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Donor or Disease Background (2021-2026)
Table 24. Global iPSC-Derived Neural Progenitor Cells Sale Price by Donor or Disease Background (2021-2026) & (US$/Dose)
Table 25. Major Players of Neural Stem Cells
Table 26. Major Players of Neural Progenitor Cells
Table 27. Major Players of Regional Neural Progenitors
Table 28. Major Players of Lineage-Committed Progenitors
Table 29. Major Players of Mature Neural Derivatives
Table 30. Major Players of Other Differentiation Stages
Table 31. Global iPSC-Derived Neural Progenitor Cells Sales by Differentiation Stage (2021-2026) & (K Dose)
Table 32. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Differentiation Stage (2021-2026)
Table 33. Global iPSC-Derived Neural Progenitor Cells Revenue by Differentiation Stage (2021-2026) & ($ million)
Table 34. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Differentiation Stage (2021-2026)
Table 35. Global iPSC-Derived Neural Progenitor Cells Sale Price by Differentiation Stage (2021-2026) & (US$/Dose)
Table 36. Major Players of Research Use Only Grade
Table 37. Major Players of Assay-Ready Grade
Table 38. Major Players of Xeno-Free Defined Grade
Table 39. Major Players of GMP-Compatible Grade
Table 40. Major Players of Custom Validated Grade
Table 41. Major Players of Other Quality Grades
Table 42. Global iPSC-Derived Neural Progenitor Cells Sales by Quality Grade (2021-2026) & (K Dose)
Table 43. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Quality Grade (2021-2026)
Table 44. Global iPSC-Derived Neural Progenitor Cells Revenue by Quality Grade (2021-2026) & ($ million)
Table 45. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Quality Grade (2021-2026)
Table 46. Global iPSC-Derived Neural Progenitor Cells Sale Price by Quality Grade (2021-2026) & (US$/Dose)
Table 47. Global iPSC-Derived Neural Progenitor Cells Sale by Application (2021-2026) & (K Dose)
Table 48. Global iPSC-Derived Neural Progenitor Cells Sale Market Share by Application (2021-2026)
Table 49. Global iPSC-Derived Neural Progenitor Cells Revenue by Application (2021-2026) & ($ million)
Table 50. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application (2021-2026)
Table 51. Global iPSC-Derived Neural Progenitor Cells Sale Price by Application (2021-2026) & (US$/Dose)
Table 52. Global iPSC-Derived Neural Progenitor Cells Sales by Company (2021-2026) & (K Dose)
Table 53. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Company (2021-2026)
Table 54. Global iPSC-Derived Neural Progenitor Cells Revenue by Company (2021-2026) & ($ millions)
Table 55. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Company (2021-2026)
Table 56. Global iPSC-Derived Neural Progenitor Cells Sale Price by Company (2021-2026) & (US$/Dose)
Table 57. Key Manufacturers iPSC-Derived Neural Progenitor Cells Producing Area Distribution and Sales Area
Table 58. Players iPSC-Derived Neural Progenitor Cells Products Offered
Table 59. iPSC-Derived Neural Progenitor Cells Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 60. New Products and Potential Entrants
Table 61. Market M&A Activity & Strategy
Table 62. Global iPSC-Derived Neural Progenitor Cells Sales by Geographic Region (2021-2026) & (K Dose)
Table 63. Global iPSC-Derived Neural Progenitor Cells Sales Market Share Geographic Region (2021-2026)
Table 64. Global iPSC-Derived Neural Progenitor Cells Revenue by Geographic Region (2021-2026) & ($ millions)
Table 65. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Geographic Region (2021-2026)
Table 66. Global iPSC-Derived Neural Progenitor Cells Sales by Country/Region (2021-2026) & (K Dose)
Table 67. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Country/Region (2021-2026)
Table 68. Global iPSC-Derived Neural Progenitor Cells Revenue by Country/Region (2021-2026) & ($ millions)
Table 69. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country/Region (2021-2026)
Table 70. Americas iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026) & (K Dose)
Table 71. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Country (2021-2026)
Table 72. Americas iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026) & ($ millions)
Table 73. Americas iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 74. Americas iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 75. APAC iPSC-Derived Neural Progenitor Cells Sales by Region (2021-2026) & (K Dose)
Table 76. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Region (2021-2026)
Table 77. APAC iPSC-Derived Neural Progenitor Cells Revenue by Region (2021-2026) & ($ millions)
Table 78. APAC iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 79. APAC iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 80. Europe iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026) & (K Dose)
Table 81. Europe iPSC-Derived Neural Progenitor Cells Revenue by Country (2021-2026) & ($ millions)
Table 82. Europe iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 83. Europe iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 84. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Country (2021-2026) & (K Dose)
Table 85. Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country (2021-2026)
Table 86. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Type (2021-2026) & (K Dose)
Table 87. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales by Application (2021-2026) & (K Dose)
Table 88. Key Market Drivers & Growth Opportunities of iPSC-Derived Neural Progenitor Cells
Table 89. Key Market Challenges & Risks of iPSC-Derived Neural Progenitor Cells
Table 90. Key Industry Trends of iPSC-Derived Neural Progenitor Cells
Table 91. iPSC-Derived Neural Progenitor Cells Raw Material
Table 92. Key Suppliers of Raw Materials
Table 93. iPSC-Derived Neural Progenitor Cells Distributors List
Table 94. iPSC-Derived Neural Progenitor Cells Customer List
Table 95. Global iPSC-Derived Neural Progenitor Cells Sales Forecast by Region (2027-2032) & (K Dose)
Table 96. Global iPSC-Derived Neural Progenitor Cells Revenue Forecast by Region (2027-2032) & ($ millions)
Table 97. Americas iPSC-Derived Neural Progenitor Cells Sales Forecast by Country (2027-2032) & (K Dose)
Table 98. Americas iPSC-Derived Neural Progenitor Cells Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 99. APAC iPSC-Derived Neural Progenitor Cells Sales Forecast by Region (2027-2032) & (K Dose)
Table 100. APAC iPSC-Derived Neural Progenitor Cells Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 101. Europe iPSC-Derived Neural Progenitor Cells Sales Forecast by Country (2027-2032) & (K Dose)
Table 102. Europe iPSC-Derived Neural Progenitor Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 103. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Forecast by Country (2027-2032) & (K Dose)
Table 104. Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue Forecast by Country (2027-2032) & ($ millions)
Table 105. Global iPSC-Derived Neural Progenitor Cells Sales Forecast by Type (2027-2032) & (K Dose)
Table 106. Global iPSC-Derived Neural Progenitor Cells Revenue Forecast by Type (2027-2032) & ($ millions)
Table 107. Global iPSC-Derived Neural Progenitor Cells Sales Forecast by Application (2027-2032) & (K Dose)
Table 108. Global iPSC-Derived Neural Progenitor Cells Revenue Forecast by Application (2027-2032) & ($ millions)
Table 109. STEMCELL Technologies Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 110. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 111. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 112. STEMCELL Technologies Main Business
Table 113. STEMCELL Technologies Latest Developments
Table 114. Merck Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 116. Merck iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 117. Merck Main Business
Table 118. Merck Latest Developments
Table 119. Applied StemCell Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 120. Applied StemCell iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 121. Applied StemCell iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 122. Applied StemCell Main Business
Table 123. Applied StemCell Latest Developments
Table 124. Axol Bioscience Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 125. Axol Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 126. Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 127. Axol Bioscience Main Business
Table 128. Axol Bioscience Latest Developments
Table 129. Tempo Bioscience Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 130. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 131. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 132. Tempo Bioscience Main Business
Table 133. Tempo Bioscience Latest Developments
Table 134. Creative Bioarray Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 135. Creative Bioarray iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 136. Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 137. Creative Bioarray Main Business
Table 138. Creative Bioarray Latest Developments
Table 139. ACROBiosystems Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 140. ACROBiosystems iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 141. ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 142. ACROBiosystems Main Business
Table 143. ACROBiosystems Latest Developments
Table 144. ATCC Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 145. ATCC iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 146. ATCC iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 147. ATCC Main Business
Table 148. ATCC Latest Developments
Table 149. Cell Applications Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 150. Cell Applications iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 151. Cell Applications iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 152. Cell Applications Main Business
Table 153. Cell Applications Latest Developments
Table 154. AcceGen Basic Information, iPSC-Derived Neural Progenitor Cells Manufacturing Base, Sales Area and Its Competitors
Table 155. AcceGen iPSC-Derived Neural Progenitor Cells Product Portfolios and Specifications
Table 156. AcceGen iPSC-Derived Neural Progenitor Cells Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 157. AcceGen Main Business
Table 158. AcceGen Latest Developments
LIST OF FIGURES
Figure 1. Picture of iPSC-Derived Neural Progenitor Cells
Figure 2. iPSC-Derived Neural Progenitor Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global iPSC-Derived Neural Progenitor Cells Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global iPSC-Derived Neural Progenitor Cells Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. iPSC-Derived Neural Progenitor Cells Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. iPSC-Derived Neural Progenitor Cells Sales Market Share by Country/Region (2025)
Figure 10. iPSC-Derived Neural Progenitor Cells Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cryopreserved Cells
Figure 12. Product Picture of Cell and Media Kits
Figure 13. Product Picture of Differentiation Kits
Figure 14. Product Picture of Disease-Specific Cells
Figure 15. Product Picture of Custom or GMP-Compatible Cells
Figure 16. Product Picture of Other Formats
Figure 17. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Type in 2026
Figure 18. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Healthy Control Donor
Figure 20. Product Picture of Patient-Derived Disease Model
Figure 21. Product Picture of Gene-Edited Reporter Line
Figure 22. Product Picture of Immune-Matched or HLA Line
Figure 23. Product Picture of Custom Donor Background
Figure 24. Product Picture of Other Donor Background
Figure 25. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Donor or Disease Background in 2026
Figure 26. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Donor or Disease Background (2021-2026)
Figure 27. Product Picture of Neural Stem Cells
Figure 28. Product Picture of Neural Progenitor Cells
Figure 29. Product Picture of Regional Neural Progenitors
Figure 30. Product Picture of Lineage-Committed Progenitors
Figure 31. Product Picture of Mature Neural Derivatives
Figure 32. Product Picture of Other Differentiation Stages
Figure 33. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Differentiation Stage in 2026
Figure 34. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Differentiation Stage (2021-2026)
Figure 35. Product Picture of Research Use Only Grade
Figure 36. Product Picture of Assay-Ready Grade
Figure 37. Product Picture of Xeno-Free Defined Grade
Figure 38. Product Picture of GMP-Compatible Grade
Figure 39. Product Picture of Custom Validated Grade
Figure 40. Product Picture of Other Quality Grades
Figure 41. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Quality Grade in 2026
Figure 42. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Quality Grade (2021-2026)
Figure 43. iPSC-Derived Neural Progenitor Cells Consumed in Neurological Disease Modeling
Figure 44. Global iPSC-Derived Neural Progenitor Cells Market: Neurological Disease Modeling (2021-2026) & (K Dose)
Figure 45. iPSC-Derived Neural Progenitor Cells Consumed in Neurotoxicity and Safety Testing
Figure 46. Global iPSC-Derived Neural Progenitor Cells Market: Neurotoxicity and Safety Testing (2021-2026) & (K Dose)
Figure 47. iPSC-Derived Neural Progenitor Cells Consumed in Drug Screening and Target Validation
Figure 48. Global iPSC-Derived Neural Progenitor Cells Market: Drug Screening and Target Validation (2021-2026) & (K Dose)
Figure 49. iPSC-Derived Neural Progenitor Cells Consumed in Neural Differentiation and Organoid Culture
Figure 50. Global iPSC-Derived Neural Progenitor Cells Market: Neural Differentiation and Organoid Culture (2021-2026) & (K Dose)
Figure 51. iPSC-Derived Neural Progenitor Cells Consumed in Regenerative Medicine Research
Figure 52. Global iPSC-Derived Neural Progenitor Cells Market: Regenerative Medicine Research (2021-2026) & (K Dose)
Figure 53. iPSC-Derived Neural Progenitor Cells Consumed in Other Applications
Figure 54. Global iPSC-Derived Neural Progenitor Cells Market: Other Applications (2021-2026) & (K Dose)
Figure 55. Global iPSC-Derived Neural Progenitor Cells Sale Market Share by Application (2025)
Figure 56. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application in 2025
Figure 57. iPSC-Derived Neural Progenitor Cells Sales by Company in 2025 (K Dose)
Figure 58. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Company in 2025
Figure 59. iPSC-Derived Neural Progenitor Cells Revenue by Company in 2025 ($ millions)
Figure 60. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Company in 2025
Figure 61. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Geographic Region (2021-2026)
Figure 62. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Geographic Region in 2025
Figure 63. Americas iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 64. Americas iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 65. APAC iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 66. APAC iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 67. Europe iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 68. Europe iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 69. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 70. Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 71. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Country in 2025
Figure 72. Americas iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country (2021-2026)
Figure 73. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 74. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 75. United States iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 76. Canada iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 77. Mexico iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 78. Brazil iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 79. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Region in 2025
Figure 80. APAC iPSC-Derived Neural Progenitor Cells Revenue Market Share by Region (2021-2026)
Figure 81. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 82. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 83. China iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 84. Japan iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 85. South Korea iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 86. Southeast Asia iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 87. India iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 88. Australia iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 89. China Taiwan iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 90. Europe iPSC-Derived Neural Progenitor Cells Sales Market Share by Country in 2025
Figure 91. Europe iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country (2021-2026)
Figure 92. Europe iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 93. Europe iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 94. Germany iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 95. France iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 96. UK iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 97. Italy iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 98. Russia iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 99. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Market Share by Country (2021-2026)
Figure 100. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 101. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 102. Egypt iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 103. South Africa iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 104. Israel iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 105. Turkey iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 106. GCC Countries iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 107. Manufacturing Cost Structure Analysis of iPSC-Derived Neural Progenitor Cells in 2026
Figure 108. Manufacturing Process Analysis of iPSC-Derived Neural Progenitor Cells
Figure 109. Industry Chain Structure of iPSC-Derived Neural Progenitor Cells
Figure 110. Channels of Distribution
Figure 111. Global iPSC-Derived Neural Progenitor Cells Sales Market Forecast by Region (2027-2032)
Figure 112. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share Forecast by Region (2027-2032)
Figure 113. Global iPSC-Derived Neural Progenitor Cells Sales Market Share Forecast by Type (2027-2032)
Figure 114. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share Forecast by Type (2027-2032)
Figure 115. Global iPSC-Derived Neural Progenitor Cells Sales Market Share Forecast by Application (2027-2032)
Figure 116. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of iPSC-Derived Neural Progenitor Cells
Figure 2. iPSC-Derived Neural Progenitor Cells Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global iPSC-Derived Neural Progenitor Cells Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global iPSC-Derived Neural Progenitor Cells Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. iPSC-Derived Neural Progenitor Cells Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. iPSC-Derived Neural Progenitor Cells Sales Market Share by Country/Region (2025)
Figure 10. iPSC-Derived Neural Progenitor Cells Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cryopreserved Cells
Figure 12. Product Picture of Cell and Media Kits
Figure 13. Product Picture of Differentiation Kits
Figure 14. Product Picture of Disease-Specific Cells
Figure 15. Product Picture of Custom or GMP-Compatible Cells
Figure 16. Product Picture of Other Formats
Figure 17. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Type in 2026
Figure 18. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Healthy Control Donor
Figure 20. Product Picture of Patient-Derived Disease Model
Figure 21. Product Picture of Gene-Edited Reporter Line
Figure 22. Product Picture of Immune-Matched or HLA Line
Figure 23. Product Picture of Custom Donor Background
Figure 24. Product Picture of Other Donor Background
Figure 25. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Donor or Disease Background in 2026
Figure 26. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Donor or Disease Background (2021-2026)
Figure 27. Product Picture of Neural Stem Cells
Figure 28. Product Picture of Neural Progenitor Cells
Figure 29. Product Picture of Regional Neural Progenitors
Figure 30. Product Picture of Lineage-Committed Progenitors
Figure 31. Product Picture of Mature Neural Derivatives
Figure 32. Product Picture of Other Differentiation Stages
Figure 33. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Differentiation Stage in 2026
Figure 34. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Differentiation Stage (2021-2026)
Figure 35. Product Picture of Research Use Only Grade
Figure 36. Product Picture of Assay-Ready Grade
Figure 37. Product Picture of Xeno-Free Defined Grade
Figure 38. Product Picture of GMP-Compatible Grade
Figure 39. Product Picture of Custom Validated Grade
Figure 40. Product Picture of Other Quality Grades
Figure 41. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Quality Grade in 2026
Figure 42. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Quality Grade (2021-2026)
Figure 43. iPSC-Derived Neural Progenitor Cells Consumed in Neurological Disease Modeling
Figure 44. Global iPSC-Derived Neural Progenitor Cells Market: Neurological Disease Modeling (2021-2026) & (K Dose)
Figure 45. iPSC-Derived Neural Progenitor Cells Consumed in Neurotoxicity and Safety Testing
Figure 46. Global iPSC-Derived Neural Progenitor Cells Market: Neurotoxicity and Safety Testing (2021-2026) & (K Dose)
Figure 47. iPSC-Derived Neural Progenitor Cells Consumed in Drug Screening and Target Validation
Figure 48. Global iPSC-Derived Neural Progenitor Cells Market: Drug Screening and Target Validation (2021-2026) & (K Dose)
Figure 49. iPSC-Derived Neural Progenitor Cells Consumed in Neural Differentiation and Organoid Culture
Figure 50. Global iPSC-Derived Neural Progenitor Cells Market: Neural Differentiation and Organoid Culture (2021-2026) & (K Dose)
Figure 51. iPSC-Derived Neural Progenitor Cells Consumed in Regenerative Medicine Research
Figure 52. Global iPSC-Derived Neural Progenitor Cells Market: Regenerative Medicine Research (2021-2026) & (K Dose)
Figure 53. iPSC-Derived Neural Progenitor Cells Consumed in Other Applications
Figure 54. Global iPSC-Derived Neural Progenitor Cells Market: Other Applications (2021-2026) & (K Dose)
Figure 55. Global iPSC-Derived Neural Progenitor Cells Sale Market Share by Application (2025)
Figure 56. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application in 2025
Figure 57. iPSC-Derived Neural Progenitor Cells Sales by Company in 2025 (K Dose)
Figure 58. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Company in 2025
Figure 59. iPSC-Derived Neural Progenitor Cells Revenue by Company in 2025 ($ millions)
Figure 60. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Company in 2025
Figure 61. Global iPSC-Derived Neural Progenitor Cells Sales Market Share by Geographic Region (2021-2026)
Figure 62. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Geographic Region in 2025
Figure 63. Americas iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 64. Americas iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 65. APAC iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 66. APAC iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 67. Europe iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 68. Europe iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 69. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales 2021-2026 (K Dose)
Figure 70. Middle East & Africa iPSC-Derived Neural Progenitor Cells Revenue 2021-2026 ($ millions)
Figure 71. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Country in 2025
Figure 72. Americas iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country (2021-2026)
Figure 73. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 74. Americas iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 75. United States iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 76. Canada iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 77. Mexico iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 78. Brazil iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 79. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Region in 2025
Figure 80. APAC iPSC-Derived Neural Progenitor Cells Revenue Market Share by Region (2021-2026)
Figure 81. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 82. APAC iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 83. China iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 84. Japan iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 85. South Korea iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 86. Southeast Asia iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 87. India iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 88. Australia iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 89. China Taiwan iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 90. Europe iPSC-Derived Neural Progenitor Cells Sales Market Share by Country in 2025
Figure 91. Europe iPSC-Derived Neural Progenitor Cells Revenue Market Share by Country (2021-2026)
Figure 92. Europe iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 93. Europe iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 94. Germany iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 95. France iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 96. UK iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 97. Italy iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 98. Russia iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 99. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Market Share by Country (2021-2026)
Figure 100. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Market Share by Type (2021-2026)
Figure 101. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Market Share by Application (2021-2026)
Figure 102. Egypt iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 103. South Africa iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 104. Israel iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 105. Turkey iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 106. GCC Countries iPSC-Derived Neural Progenitor Cells Revenue Growth 2021-2026 ($ millions)
Figure 107. Manufacturing Cost Structure Analysis of iPSC-Derived Neural Progenitor Cells in 2026
Figure 108. Manufacturing Process Analysis of iPSC-Derived Neural Progenitor Cells
Figure 109. Industry Chain Structure of iPSC-Derived Neural Progenitor Cells
Figure 110. Channels of Distribution
Figure 111. Global iPSC-Derived Neural Progenitor Cells Sales Market Forecast by Region (2027-2032)
Figure 112. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share Forecast by Region (2027-2032)
Figure 113. Global iPSC-Derived Neural Progenitor Cells Sales Market Share Forecast by Type (2027-2032)
Figure 114. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share Forecast by Type (2027-2032)
Figure 115. Global iPSC-Derived Neural Progenitor Cells Sales Market Share Forecast by Application (2027-2032)
Figure 116. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share Forecast by Application (2027-2032)
